Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

The Number and Potency of Endothelial Progenitor Cells in Type 2 Diabetes Mellitus Patients

The Indonesian Biomedical Journal · Vol. 11 No. 2 (2019) · hlm. 205–209

DOI
10.18585/inabj.v11i2.576
ISSN
2085-3297, 2355-9179
Terbit
2019-08-01
Penerbit
Secretariat of The Indonesian Biomedical Journal
Bahasa
en
Lisensi
creativecommons.org/licenses/by-nc/4.0/

Abstrak

BACKGROUND: Type 2 Diabetes Mellitus (T2DM) is a metabolic disease, due to the disorder of insulin function, insulin secretion, or both. Long-term hyperglycemia conditions promote endothelial dysfunction precedes to the development of multiple organ dysfunctions. Endothelial progenitor cells (EPCs) and hematopoietic stem cell (HSCs) are the key cellular effectors of postnatal neovascularization and play central role in endothelial dysfunction. However, in T2DM condition, the number of apoptotic HSCs increase, it may cause the reduction in potency and number of EPCs. In diabetes, the circulating EPCs number decrease and their functionality is impaired, but mechanism underlie of this impairement is unknown. The purpose of this study was to examine the relationship duration diabetes with the number and potency of EPC cells in T2DM patients controlled and poorly controlled.METHODS: Thirty-eight T2DM male patients were classified into two group based on Indonesian Society of Endocrinology/Perkumpulan Endokrinologi Indonesia (PERKENI) criteria on T2DM. The first group was a controlled glycemic condition group (hemoglobin A1c (HbA1C) 7.0%). Cluster of differentiation (CD)34+ and CD133+ expressions were used as specific marker for EPC, while quantified bright aldehyde dehydrogenase (ALDHbr) assay was used to represented the potency of EPCs.RESULTS: This study showed that in poorly controlled T2DM group the number of EPCs was lower by 24.80% (p<0.05) compared to the T2DM controlled group. Similarly, the expression of ALDHbr was lower by 43.07% (p<0.05) in poorly controlled group.CONCLUSION: There was a decrease in the number and potency of EPCs in poorly controlled T2DM patients compared to the controlled T2DM patients. There was also a strong negative correlation between the duration of diabetes and number of EPCs.KEYWORDS: ALDHbr, endothelial progenitor cells, type 2 diabetes mellitus

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 187 tautan kepenulisan bersama · 91 lintas organisasi · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Padjadjaran University
  • PT Prodia StemCell Indonesia (Indonesia)
  • Hasanuddin University
  • IPB University
  • Dr. Hasan Sadikin General Hospital
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Andi WijayaHasanuddin University5
Rima HaifaPT Prodia StemCell Indonesia (Indonesia)4
Albertus Budi SulistyaPadjadjaran University2
Geofanny FaciciliaPT Prodia StemCell Indonesia (Indonesia)2
Nisa ZulfaniPT Prodia StemCell Indonesia (Indonesia)2
Yussy Afriani DewiPadjadjaran University2
Bayu Winata PuteraHasanuddin University2
Ahmad FariedPadjadjaran University2
Keri LestariPadjadjaran University2
Mawar SubangkitIPB University1
Keri LestariPadjadjaran University1
Cecilia Aileen YapPT Prodia StemCell Indonesia (Indonesia)1
Elpita TariganAfiliasi tidak diketahui1
Yusa IrarangAfiliasi tidak diketahui1
Sri Adi SumiwiPadjadjaran University1
Sandra MegantaraPadjadjaran University1
Jutti LevitaPadjadjaran University1
Ade ZuhrotunPadjadjaran University1
Mochamad RizalPadjadjaran University1
Ajeng DiantiniPadjadjaran University1
Angliana ChouwPT Prodia StemCell Indonesia (Indonesia)1
Keri Lestari DandanPadjadjaran University1
Kristin Talia MarbunPT Prodia StemCell Indonesia (Indonesia)1
Marsya Nilam KiranaPT Prodia StemCell Indonesia (Indonesia)1
Muhammad Agus AuliaPadjadjaran University1
Achmad AdamDr. Hasan Sadikin General Hospital1
Hanna GunawanPadjadjaran University1
N.F. Farah NauraPT Prodia StemCell Indonesia (Indonesia)1
Billy Yosua Costantin PongajowPT Prodia StemCell Indonesia (Indonesia)1
Suryani As’ádHasanuddin University1
Nurrani Mustika DewiPadjadjaran University1
Rina TrianaPadjadjaran University1
Made Putra SemadhiPadjadjaran University1
Miftakh Nur RahmanPadjadjaran University1
Eka HerawatiPadjadjaran University1
Maria NovalentinaPadjadjaran University1
Muhammad Agus AuliaPadjadjaran University1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S2764892910, pertama di-harvest 19 Nov 2026, terakhir terlihat 19 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">The Number and Potency of Endothelial Progenitor Cells in Type 2 Diabetes Mellitus Patients</dc:title><dc:creator>Siska Darmayanti</dc:creator><dc:creator>Rini Hendriani</dc:creator><dc:creator>Cynthia Retna Sartika</dc:creator><dc:subject>endothelial progenitor cells</dc:subject><dc:subject>type 2 diabetes</dc:subject><dc:subject>glycemic control</dc:subject><dc:subject>aldehyde dehydrogenase</dc:subject><dc:subject>endothelial dysfunction</dc:subject><dc:subject>diabetes duration</dc:subject><dc:subject>CD34</dc:subject><dc:subject>CD133</dc:subject><dc:subject>hematopoietic stem cells</dc:subject><dc:subject>hyperglycemia</dc:subject><dc:description xml:lang="en">BACKGROUND: Type 2 Diabetes Mellitus (T2DM) is a metabolic disease, due to the disorder of insulin function, insulin secretion, or both. Long-term hyperglycemia conditions promote endothelial dysfunction precedes to the development of multiple organ dysfunctions. Endothelial progenitor cells (EPCs) and hematopoietic stem cell (HSCs) are the key cellular effectors of postnatal neovascularization and play central role in endothelial dysfunction. However, in T2DM condition, the number of apoptotic HSCs increase, it may cause the reduction in potency and number of EPCs. In diabetes, the circulating EPCs number decrease and their functionality is impaired, but mechanism underlie of this impairement is unknown. The purpose of this study was to examine the relationship duration diabetes with the number and potency of EPC cells in T2DM patients controlled and poorly controlled.METHODS: Thirty-eight T2DM male patients were classified into two group based on Indonesian Society of Endocrinology/Perkumpulan Endokrinologi Indonesia (PERKENI) criteria on T2DM. The first group was a controlled glycemic condition group (hemoglobin A1c (HbA1C) &lt;7.0%) and the second group was a poorly controlled glycemic condition group (HbA1C &gt;7.0%). Cluster of differentiation (CD)34+ and CD133+ expressions were used as specific marker for EPC, while quantified bright aldehyde dehydrogenase (ALDHbr) assay was used to represented the potency of EPCs.RESULTS: This study showed that in poorly controlled T2DM group the number of EPCs was lower by 24.80% (p&lt;0.05) compared to the T2DM controlled group. Similarly, the expression of ALDHbr was lower by 43.07% (p&lt;0.05) in poorly controlled group.CONCLUSION: There was a decrease in the number and potency of EPCs in poorly controlled T2DM patients compared to the controlled T2DM patients. There was also a strong negative correlation between the duration of diabetes and number of EPCs.KEYWORDS: ALDHbr, endothelial progenitor cells, type 2 diabetes mellitus</dc:description><dc:publisher>Secretariat of The Indonesian Biomedical Journal</dc:publisher><dc:date>2019-08-01</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>https://doi.org/10.18585/inabj.v11i2.576</dc:identifier><dc:identifier>10.18585/inabj.v11i2.576</dc:identifier><dc:source>The Indonesian Biomedical Journal; Vol 11 No 2 (2019); 205-209</dc:source><dc:source>2085-3297</dc:source><dc:source>2355-9179</dc:source><dc:language>en</dc:language><dc:relation>https://inabj.org/index.php/ibj/article/download/576/436</dc:relation><dc:rights>https://creativecommons.org/licenses/by-nc/4.0/</dc:rights></oai_dc:dc>